CBMA | Cannabis-Based Medicines Association

Science & evidence

Science and evidence

Cannabis-based medicines can only become a trusted part of mainstream healthcare if decisions are based on evidence.

Today, that evidence is too limited, and there is no standardised collection of real-world data in the UK.

Our approach

Building evidence,
together

  1. 01

    Partnerships with clinics

    Collecting real-world data on outcomes and safety, consistently and with clinicians.

  2. 02

    A shared data collection tool

    A shared tool for members and partner clinics to support consistent real-world data collection.

  3. 03

    Patient-centred measures

    Quality of life, treatment efficacy, safety and adverse effects, and health economic evidence.

  4. 04

    Clinical and research collaboration

    Working with clinicians and researchers, including the Medical Cannabis Clinicians Society (MCCS).

Patient outcomes

What we will measure

Quality of life

Treatment efficacy

Safety & adverse effects

Health economic evidence

Our progress

Milestones & findings

We will publish our progress and findings on this page as the work develops.

  1. Milestone 1

    Details and status to be confirmed
  2. Milestone 2

    Details and status to be confirmed

Help shape it from day one

Book a 30-minute call to see the full plan.

Register your interest →